Objectives This review aims to present the main interactions between contraceptive methods
and psychotropic therapy and its impact on psychiatric disorders, in addition to the …

Objective: Mental health care for women includes decision support to prepare for major life
events, including preconception planning for treatment during pregnancy and the …

Purpose Depressive symptoms often occur among women of reproductive age. In this article
we perform an analysis of existing studies to examine a possible correlation between …

Among the most prevalent and disabling chronic diseases affecting reproductive-aged
women worldwide, depression and anxiety can contribute to adverse reproductive health …

Hormonal contraceptives are used worldwide by more than 100 million women. Some
studies have been published about the possible appearance of depressive symptoms when …

Objective Over the past decades, an increasing number of women have been using
hormonal contraception. The potential role of sex hormones in regulating vegetative …

Mood changes and irritability in the context of hormonal contraception (HC) are discussed in
Chapter 17. The most relevant symptoms of MD patients are demonstrated in Table 26.1 …

Mental health disorders, which are among the most prevalent chronic diseases affecting
reproductive-aged women worldwide, can have adverse reproductive health consequences …

Barriers to effective contraceptive use should be addressed and myths on negative
psychiatric impacts of hormonal contraceptives should be dispelled. Healthcare clinicians …

Objective To examine whether the co-administration of hormonal contraceptives (HC) and
psychotropic drugs commonly used to treat anxiety and/or depression results in safety or …